Boundless Bio, Inc.
BOLD
$1.07
-$0.01-1.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.60% | -6.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.21% | -1.61% | |||
| Operating Income | 11.21% | 1.61% | |||
| Income Before Tax | 11.46% | 0.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.46% | 0.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.46% | 0.53% | |||
| EBIT | 11.21% | 1.61% | |||
| EBITDA | 11.38% | 1.64% | |||
| EPS Basic | 11.58% | 0.76% | |||
| Normalized Basic EPS | 11.57% | 0.77% | |||
| EPS Diluted | 11.58% | 0.76% | |||
| Normalized Diluted EPS | 11.57% | 0.77% | |||
| Average Basic Shares Outstanding | 0.13% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||